. Author manuscript; available in PMC: 2021 Feb 1.

Published in final edited form as: FASEB J. 2019 Dec 23;34(2):2497–2510. doi: 10.1096/fj.201900897R

Table II.

Peritoneal Cavity Fluid Macrophage Phenotypes

Cell population	Sham (n=5)	CLP + Vehicle (n=8)	CLP + PKCδ Inhibitor (n=6)
CD68+CD86+(% of CD45+ cells)	48.6 ± 9.74	17.8 ± 1.32 ^***	22.7 ± 2.15 ^*§
CD163+(% of CD68+CD86+ cells)	19.2 ± 2.33	9.59 ± 1.96 ^**	6.62 ± 0.71 ^***
CCR2+(% of CD68+CD86+CD163+ cells)	2.68 ± 0.63	9.75 ± 2.25 ^*	6.27 ± 1.79
CD163-(% of CD68+CD86+ cells)	73.5 ± 3.14	86.5 ± 2.45 ^**	91.1 ± 1.27 ^***
CCR2+ (% of CD68+CD86+CD163- cells)	2.32 ± 0.37	6.53 ± 1.90	4.25 ± 1.48

p < 0.05 relative to Sham

^**

p < 0.01 relative to Sham

^***

p < 0.001 relative to Sham

^§

p < 0.05 relative to CLP + vehicle